List of works - Robert Zeiser

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model ⬇️

scientific article published on May 21, 2013

Advances in understanding the pathogenesis of graft-versus-host disease

scientific article published on 06 October 2019

B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model

scientific article published on 18 January 2019

B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells

scientific article

Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 15 January 2019

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation ⬇️

scientific article published on October 28, 2010

CXCL12 Mediates Immunosuppression in the Lymphoma Microenvironment after Allogeneic Transplantation of Hematopoietic Cells ⬇️

scientific article published on December 15, 2010

Clinical implications of tumor-intrinsic mechanisms regulating PD-L1

scientific article published on 01 February 2019

Danger signals activating innate immunity in graft-versus-host disease ⬇️

scientific article published on May 15, 2011

Ectonucleotidases in Solid Organ and Allogeneic Hematopoietic Cell Transplantation ⬇️

scientific article published on October 16, 2012

Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells

scientific article published on 01 November 2018

HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice

scientific article published on 17 August 2020

High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis ⬇️

scientific article published on January 17, 2012

Immune modulatory effects of oncogenic KRAS in cancer

scientific article published on 28 October 2020

Immune modulatory effects of statins.

scientific article published on 2 February 2018

Immunotherapy for Malignant Melanoma Robert ⬇️

scientific article published on May 1, 2012

Immunotherapy in Myeloproliferative Diseases

scientific article published on 26 June 2020

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells ⬇️

scientific article published on July 16, 2012

Introduction to a review series on strategies to improve GVL effects.

scientific article published on 22 January 2018

Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity ⬇️

scientific article published on November 8, 2010

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism ⬇️

scientific article published on January 21, 2011

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

scientific article published on 01 October 2020

Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.

scientific article

Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms.

scientific article published in February 2018

P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema

scientific article published on 27 May 2010

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

scientific article published on 31 October 2020

Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema.

scientific article published on 2 June 2010

ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease

scientific article published in 2024

Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease

scientific article published on 17 November 2020

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)

scientific article published on 16 July 2020

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

scientific article published on 12 February 2018

Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels ⬇️